Patients in 33 regions complained of problems obtaining glucagon Diabetics in at least 33 regions of Russia encountered difficulties in obtaining glucagon, an emergency drug for severe hypoglycemia. This is what Izvestia reported with reference to patient organizations. According to the patients, the wait for the drug for preferred prescriptions lasts from two weeks to several months. In some cases, the doctors do not write prescriptions even if there are indications, explaining this with a lack of drugs and recommending in an emergency case of a drop in glucose levels to seek urgent medical help. Glucagon is used for severe hypoglycemia, when the patient cannot take carbohydrates by himself, including in cases of impaired consciousness. The drug is especially important for people with diabetes who receive insulin therapy. The drug "GlucaGen 1 mg HypoKit" from Novo Nordisk (INN - Glucagon) is registered in Russia. Registration certificate No. LP-No. (010671)-(GP-RU). According to the State Register of Maximum Selling Prices, as of June 17, 2026, the manufacturer's maximum selling price without VAT is 1001.26 rubles. ANO Diaresurs project manager Yulia Pankova linked the disturbances to the re-registration of the drug. According to her, the required procedures have been completed, the supply has been resumed, but the cumulative need remains the same. Problems affect not only the actual availability of the drug, but also the registration of prescriptions. In the Leningrad region, the territorial body of Rushdrabendzor issued a warning to the Tosano hospital on October 16 after detecting violations when writing a prescription for glucagon. Despite the medical board's decision on April 1, the patient was unable to obtain a prescription for several months. Read us in Max Telegram VK.

Patients in 33 regions complained of problems obtaining glucagon Diabetics in at least 33 regions of Russia encountered difficulties in obtaining glucagon, an emergency drug for severe hypoglycemia. This is what Izvestia reported with reference to patient organizations. According to the patients, the wait for the drug for preferred prescriptions lasts from two weeks to several months. In some cases, the doctors do not write prescriptions even if there are indications, explaining this with a lack of drugs and recommending in an emergency case of a drop in glucose levels to seek urgent medical help. Glucagon is used for severe hypoglycemia, when the patient cannot take carbohydrates by himself, including in cases of impaired consciousness. The drug is especially important for people with diabetes who receive insulin therapy. The drug "GlucaGen 1 mg HypoKit" from Novo Nordisk (INN - Glucagon) is registered in Russia. Registration certificate No. LP-No. (010671)-(GP-RU). According to the State Register of Maximum Selling Prices, as of June 17, 2026, the manufacturer's maximum selling price without VAT is 1001.26 rubles. ANO Diaresurs project manager Yulia Pankova linked the disturbances to the re-registration of the drug. According to her, the required procedures have been completed, the supply has been resumed, but the cumulative need remains the same. Problems affect not only the actual availability of the drug, but also the registration of prescriptions. In the Leningrad region, the territorial body of Rushdrabendzor issued a warning to the Tosano hospital on October 16 after detecting violations when writing a prescription for glucagon. Despite the medical board's decision on April 1, the patient was unable to obtain a prescription for several months. Read us in Max Telegram VK.